Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fritsch

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy aloneE Dühmke, J Franklin, M Pfreundschuh, et al.
Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2019
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort ValidationJudith Wienke, Felicitas Bellutti Enders, Johan Lim, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy aloneE Dühmke, J Franklin, M Pfreundschuh, et al.
Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2019
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort ValidationJudith Wienke, Felicitas Bellutti Enders, Johan Lim, et al.
Pageof 9